Fang Liu
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$1.2MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 21, 2023 | DoD | SBIR Phase I Novel Aerosol Therapy for Immediate and Sustained ARDS Management | $250K | ZYMERON CORPORATION |
| Mar 16, 2022 | DoD | SBIR Phase I Small Molecule Therapeutics Targeting Members of the Bunyavirales Order | $167K | ZYMERON CORPORATION |
| Jan 8, 2021 | DoD | STTR Phase I Large Area Opioid Identification by Bioengineered Broad-Spectrum Receptors | $167K | ZYMERON CORPORATION with Trustees of the University of Pennsylvania |
| — | NIH | SBIR Phase I THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN, SYNTHESIZE COMPOUNDS THAT BIND TO NEF, AN HIV ACCESSORY PROTEIN. | $300K | ZYMERON CORPORATION |
| — | NIH | SBIR Phase I SBIR PHS 2020-1, TOPIC 084 ENTITLED ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION | $300K | ZYMERON CORPORATION |
Peer ranks
Federal funding#1,938
Awards as PI#470
Patents#505
Companies
- ZYMERON CORPORATIONLinked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.